Nomination Committee appointed ahead of Getinge's Annual General Meeting 2027
The members of the Nomination Committee for Getinge AB's Annual General Meeting 2027 have now been appointed.
In accordance with the principles adopted at the 2020 Annual General Meeting, the Nomination Committee ahead of the Annual General Meeting shall consist of members appointed by the four largest shareholders in terms of voting rights as of August 31 each year, as well as the Chairman of the Board.
Getinge’s Nomination Committee ahead of the Annual General Meeting 2027 has now been appointed and consists of the company’s Chairman of the Board, Johan Malmquist, and representatives appointed by the following shareholders, in order of voting power:
- Carl Bennet, Carl Bennet AB, Chairman of the Nomination Committee
- Sophie Larsén, AMF Pension & Fonder
- Anna Magnusson, Fourth Swedish National Pension Fund
- Anna Strömberg, Carnegie Fonder
The task of the Nomination Committee is to prepare proposals for the 2027 Annual General Meeting regarding the Chairman of the Meeting, the number of Board members, the remuneration to each of the Board members, the election of the Board of Directors and the Chairman of the Board, the remuneration to the auditor and the election of the auditor, as well as, to the extent deemed necessary, proposals for changes to the Nomination Committee’s instructions.
Shareholders who wish to submit proposals to the Nomination Committee can contact the Nomination Committee by e-mail at valberedningen@getinge.com or by mail to the following address:
Getinge AB (publ)
Att: Valberedningen
Box 8861
SE-402 72 Göteborg
SWEDEN
Proposals must be received by the Nomination Committee no later than January 15, 2027, in order to ensure that they are addressed by the Committee.
For more information, please contact:
David Kördel, Head of Investor Relations
Phone: +46 (0)10 335 0077
E-mail: david.kordel@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.
Nomination Committee appointed ahead of Getinge's Annual General Meeting 2027